Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. was incorporated on August 24, 2007. Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. currently employs 61 (2020) people. The latest financial highlights indicate a net sales revenue drop of 8.54% in 2023. Its’ total assets recorded a growth of 8.32%. The enterprise’s net profit margin decreased by 8.16% in 2023.

Headquarters
Ul. Chelmska 30/34
Warsaw; Mazowieckie; Postal Code: 00-725

Contact Details: Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.

Website: http://www.biomed.com.pl

Basic Information

Total Employees:

Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.

Incorporation Date:

August 24, 2007

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

100%

Subsidiaries

Biomed Produkcja Sp. z o.o.

100%

Company Performance

Financial values in the chart are available after Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-8.54%▼

Total operating revenue

-0.98%▼

Operating profit (EBIT)

-37.44%▼

EBITDA

-32.81%▼

Net Profit (Loss) for the Period

-40.34%▼

Total assets

8.32%▲

Total equity

19.84%▲

Operating Profit Margin (ROS)

-9.77%▼

Net Profit Margin

-8.16%▼

Return on Equity (ROE)

-23.01%▼

Debt to Equity Ratio

-9.15%▼

Quick Ratio

-0.24%▼

Cash Ratio

-0.13%▼

Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. (Poland)